IMNM Competitors & Alternatives
Compare Immunome Inc with similar stocks in the same industry
Biotechnology
IMNM
Main Stock$18.46
Tradestie Score
46
Market Cap
$987.09M
Revenue Growth
-1.0%
Analyst Upside
+90.7%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$6.19
|
$2.34B | - | 40 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$83.51
|
$2.33B | - | 46 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$32.02
|
$2.33B | - | 44 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.42
|
$2.23B | - | 57 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.42
|
$2.22B | - | 40 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$52.16
|
$2.21B | - | 57 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$19.32
|
$2.18B | - | 52 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$13.20
|
$2.08B | - | 43 | Compare |
More IMNM Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry